IGC Pharma, Inc. (IGC): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-10, first reflected in a filing dated 2013-07-16. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

80.88M

As of 2025-03-31

+16.6%

3-year compound annual growth

+15.5%

5-year compound annual growth

+18.5%

10-year compound annual growth

2011-03-31 Shares Outstanding (shares) 2025-03-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-03-31	80.88M	+21.3%	2025-06-27, Balance as of period end
2024-03-31	66.69M	+25.6%	2025-06-27, Balance as of period end
2023-03-31	53.08M	+4.0%	2024-06-24, Balance as of period end
2022-03-31	51.05M	+6.7%	2023-07-07, Balance as of period end
2021-03-31	47.83M	+21.6%	2022-06-23, Balance as of period end
2020-03-31	39.32M	-0.5%	2021-06-14, Balance as of period end
2019-03-31	39.50M	+28.4%	2020-07-13, Balance as of period end
2018-03-31	30.76M	+8.8%	2019-06-14, Balance as of period end
2017-03-31	28.27M	+21.5%	2018-06-21, Balance as of period end
2016-03-31	23.27M	+57.6%	2017-07-14, Balance as of period end
2015-03-31	14.77M	+57.5%	2016-07-14, Balance as of period end
2014-03-31	9.37M	+34.3%	2015-07-14, Balance as of period end
2013-03-31	6.98M	+16.2%	2014-07-15, Balance as of period end
2012-03-31	6.01M	n/c	2014-07-15, Balance as of period end
2011-03-31	14.89M	n/a	2012-07-16, Balance as of period end